CoChat

Diabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease

Bertot, Luis C., Jeffrey, Gary P., de Boer, Bastiaan, MacQuillan, Gerry, Garas, George, Chin, Justin, Huang, Yi, Adams, Leon A. · 2018 · Liver International
Cited by 120

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background & Aims: Non‐alcoholic fatty liver disease (NAFLD) patients with diabetes are at increased risk of cirrhosis and liver‐related death, and thus accurate fibrosis assessment in these patients is important. We examined the ability of non‐invasive fibrosis models to determine cirrhosis and outcomes in NAFLD patients with and without diabetes. Methods: Non‐alcoholic fatty liver disease patients diagnosed between 2006 and 2015 had Hepascore, NAFLD fibrosis score (NFS), APRI and FIB‐4 scores calculated at baseline and were followed up for outcomes of overall and liver‐related mortality/liver transplantation, hepatic decompensation and hepatocellular carcinoma (HCC). Model accuracy was determined by Harrell's C‐index and by Kaplan‐Meier analysis. Results: A total of 284 patients (53% diabetic, 15% cirrhotic) were followed up for a median of 51.4 months, (range 6.1‐146). During follow‐up, diabetic patients had a greater risk of liver‐related death/transplantation, HR 3.4 (95% CI 1.2‐9.1) decompensation, HR 4.7 (95% CI 2.0‐11.3) and HCC, HR 2.9 (95% CI 1.2‐7.3). Among 241 subjects with a baseline liver biopsy, the accuracy of Hepascore, APRI and FIB‐4 for predicting cirrhosis was lower amongst diabetics compared to non‐diabetics (P < .005 for all). Model accuracy apart from Hepascore, was also significantly lower for predicting liver death/transplantation in patients with diabetes. No patient with a low fibrosis score and without diabetes developed liver decompensation or HCC, whereas up to 21% of diabetic patients with a low fibrosis score developed liver decompensation and up to 27% developed HCC at 5 years. Conclusions: Non‐invasive scoring systems are less accurate at predicting cirrhosis and liver‐related outcomes in patients with NAFLD and diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.13739

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 120

Metadata

Authors
Bertot, L. C., Jeffrey, G. P., de Boer, B., MacQuillan, G., Garas, G., Chin, J., Huang, Y., & Adams, L. A.
Venue
Liver International
Publisher
Wiley
Published
2018-03-31
Volume
38
Issue
10
Pages
1793-1802
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2789990346
Cited by
120
References
12
FWCI
9.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1111/liv.13739
The paper
Bertot, L. C., Jeffrey, G. P., de Boer, B., MacQuillan, G., Garas, G., Chin, J., Huang, Y., & Adams, L. A. (2018). Diabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease. Liver International. https://doi.org/10.1111/liv.13739

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.